ePoster
Switch To Module
Conference Calendar
ePoster
Name Search
Filter By
Presentation Topic
AS01. Basic Science
Select All
Deselect All
AS1.01 Taxonomy
2
AS1.02 Animal Models
1
AS1.03 Immunology
7
AS1.04 Regulation of Gene Expression
4
AS1.05 Transformation and Carcinogenesis
2
AS1.07 Virus – Host Interactions
5
AS1.09 Genomics of HPV-associated Disease
7
AS1.10 Papillomavirus Vaccines (i.e New Developments)
3
AS1.11 Beta and Gamma Cutaneous HPV Infection, Biology, and Natural History
1
AS1.12 Microbiome
4
AS1.13 Other Basic Research
6
AS02. Clinical Research
Select All
Deselect All
AS02. Clinical Research
3
AS2.01 HPV Diagnostics and Biomarkers for Early Detection and Prognosis of HPV-related Cancers
21
AS2.02 Self-sampling for HPV collection
14
AS2.03 Diagnosis and Management of Cervical Cancer and related Precursors
7
AS2.05 Diagnosis and Management of Oropharyngeal, Head and Neck Cancer
1
AS2.06 Diagnosis and Management of Genital and Cutaneous Warts
4
AS2.08 Prophylactic Vaccines – Clinical Aspects
2
AS2.09 Therapeutic Vaccines – Clinical Aspects
3
AS2.10 Management of HPV disease in HIV-infected People
2
AS2.12 Treatment of HPV-related Disease
9
AS2.13 Recurrent Respiratory Papillomatosis
2
AS2.15 Other Clinical Research
5
AS03. Public Health, Epidemiology and Implementation Science
Select All
Deselect All
AS03. Public Health, Epidemiology and Implementation Science
1
AS3.01 Global Impact of HPV and Cervical Cancer Prevention
7
AS3.02 Epidemiology: Natural History/Risk Factors
33
AS3.03 Screening for HPV-related Disease: Implementation, Evaluation and Impact
42
AS3.04 Vaccination: Implementation, Evaluation and Impact
17
AS3.05 Economics and Mathematical Modelling
7
AS3.06 Primary HPV VS Co-testing with HPV and Cytology
2
AS3.07 Psychological Aspects on HPV-related Interventions
4
AS3.08 Dissemination/Communication Research
7
AS3.09 Cervical Cancer Elimination
10
AS3.11 Impacts of COVID-19 pandemic on HPV vaccination implementation
5
AS3.12 Impacts of COVID-19 pandemic on public health aspects of HPV screening
5
AS3.13 Other Public Health, Epidemiology and Implementation Science Research
26
Session Name
Select All
Deselect All
E-Poster Viewing
256
Featured E-Posters
25
Cancel
Clear
Search
E-Posters
Name Search
HPV16 SUB-LINEAGE IDENTIFICATION IN ANAL CANCER BIOPSIES BY NGS AND ASSOCIATION WITH OVERALL SURVIVAL
(ID 588)
HPV16 SUB-LINEAGE IDENTIFICATION IN ANAL CANCER BIOPSIES BY NGS AND ASSOCIATION WITH OVERALL SURVIVAL
(ID 588)
Presenter
D. Guerendiain
Authors
D. Guerendiain
R. Grigorescu
M. Holden
K. Cuschieri
My link to connect
https://us02web.zoom.us/j/87994362238?pwd=OXJZeG8xL1ZNUzQzUUVUcUNiQ1puZz09
Availability
16/11/2021 16:00 - 16:30 Toronto time / 21:00 - 21:30 UK time
Previous Poster
Next Poster
My link to connect
Availability
My link to connect
https://us02web.zoom.us/j/87994362238?pwd=OXJZeG8xL1ZNUzQzUUVUcUNiQ1puZz09
Hide
Availability
16/11/2021 16:00 - 16:30 Toronto time / 21:00 - 21:30 UK time
Hide
Previous ePoster
USE OF URINE SPECIMENS FOR THE DETECTION OF GENITAL HPV INFECTION IN MALES AND FEMALES: PROTOCOL FOR A SYSTEMATIC REVIEW AND META-ANALYSIS
(ID 563)
Next ePosters
HUMAN PAPILLOMAVIRUS INFECTIONS AND THE IMPACT OF VIRAL LOAD IN WOMEN ATTENDING THE GYNECOLOGY CLINIC AT DR GEORGE MUKHARI ACADEMIC HOSPITAL, SOUTH AFRICA
(ID 865)
DIAGNOSTIC PERFORMANCE OF ORAL HPV DNA, ORAL HPV RNA, AND PLASMA CIRCULATING TUMOR HPV DNA FOR HPV-RELATED OROPHARYNGEAL CANCER AND CANCER OF UNKNOWN PRIMARY
(ID 875)
CLINICAL VALIDATION OF THE NEUMODX HPV ASSAY IN POPULATION-BASED CERVICAL CANCER SCREENING SETTING
(ID 877)
HPV ONCOPREDICT: CLINICAL PERFORMANCE OF A NEW REFLEX HR-HPV DNA ASSAY
(ID 948)
MINICHROMOSOME MAINTENANCE PROTEIN (MCM)-7 IMMUNOLABELING IN CERVICAL CANCER DIFFERENTIATION AND ITS CORRELATION WITH HPV
(ID 949)
EVALUATION OF MCM7 AND ALPHA-INIBIN PROTEINS AS VALUABLE BIOMARKERS FOR THE CERVICAL CANCER PROGNOSIS
(ID 957)
FLOQSWABS® FOR CERVICAL AND VAGINAL PHYSICIAN SPECIMEN’S COLLECTION AND PATIENT’S VAGINAL SELF-COLLECTED SPECIMENS FOR HPV DETECTION USING THE HPV QUANT QUANTITATIVE REAL-TIME PCR ASSAYS.
(ID 52)
HIGH-RISK HUMAN PAPILLOMAVIRUS DETECTION IN SELF-COLLECTED APPLICATOR-TAMPON SAMPLES COMPARED TO HEALTHCARE WORKER-COLLECTED SAMPLES IN GYNAECOLOGY-CLINIC ATTENDEES AT A TERTIARY HOSPITAL IN SOUTH AFRICA
(ID 87)
INFLUENCE OF RESUSPENSION VOLUME ON DRY SAMPLING DEVICES TAKEN FOR HPV TESTING; IMPLICATIONS FOR SELF-SAMPLING
(ID 132)
HE TAPU TE WHARE TANGATA (THE SACRED HOUSE OF HUMANITY): LEARNING FROM INDIGENOUS MĀORI WOMEN ABOUT A HUMAN PAPILLOMAVIRUS SELF-TEST BASED CERVICAL SCREENING CLINICAL PATHWAY
(ID 210)
Please add your email also in the body of the message in order to get a reply